Carvedilol Tablet, Film Coated
Product Images NDC 72789-537

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 72789-537). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structured Formula For Carvedilol (2c528763 Eac4 4001 A828 95a981ad29b1 01)

Chemical structure of carvedilol, showing its molecular arrangement with aromatic rings and functional groups.*

FDA Label Image

Carvedilol Tablets (2c528763 Eac4 4001 A828 95a981ad29b1 02)

A line graph comparing the percentage mortality over a period of 21 months between two groups labeled 'Placebo' and 'Carvedilol'. The y-axis represents % mortality, ranging from 0 to 30%, and the x-axis shows time in months from 0 to 21. The 'Carvedilol' group shows consistently lower mortality than the 'Placebo' group, with a statistical significance indicated by P = 0.0014.*

FDA Label Image

Carvedilol Tablets (2c528763 Eac4 4001 A828 95a981ad29b1 03)

A chart depicting hazard ratios with confidence intervals for different patient subgroups, including men, women, age groups, race, diabetic status, ischemic condition, heart rate, systolic blood pressure, and spironolactone use, with a reference line at hazard ratio 1.0.*

FDA Label Image

Structured Formula For Carvedilol (2c528763 Eac4 4001 A828 95a981ad29b1 04)

A line graph comparing mortality percentages over 24 months for Carvedilol 12.5 mg tablets versus placebo. The x-axis shows time in months, and the y-axis indicates percentage mortality. Two curves represent the Carvedilol and placebo groups, with a p-value of 0.03 noted on the graph.*

FDA Label Image

Structured Formula For Carvedilol (2c528763 Eac4 4001 A828 95a981ad29b1 05)

A forest plot displaying hazard ratios for various patient subgroups including age, sex, myocardial infarction timing, beta-blocker use, Killip classification, thrombolytic therapy, percutaneous transluminal coronary angioplasty (PTCA) use, heart failure status, concurrent diuretic therapy, angina, hypertension, diabetes, heart rate, and systolic blood pressure. The horizontal axis represents hazard ratio values ranging approximately from 0.4 to 1.3, with data points and confidence intervals shown for each subgroup.*

FDA Label Image

72789537 Label (72789537)

Carvedilol Tablets, USP 12.5 mg film-coated tablets label for a 180 tablet package. The label includes storage instructions to keep at 20° to 25°C and to protect from moisture. Marketed and packaged by PD-Rx Pharmaceuticals, Inc., Oklahoma City, OK, and manufactured by Zydus Lifesciences Ltd., India. The label features barcodes, QR codes for prescribing information, and warnings to keep medications out of children's reach.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.